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Background
In this document, the Inter-American Committee of Cardiovascular Prevention and Rehabilitation, together with the South American Society of Cardiology, aimed to formulate strategies, measures, and actions for cardiovascular disease prevention and rehabilitation (CVDPR). In the context of the implementation of a regional and national health policy in Latin American countries, the goal is to promote cardiovascular health and thereby decrease morbidity and mortality. The study group on Cardiopulmonary and Metabolic Rehabilitation from the Department of Exercise, Ergometry, and Cardiovascular Rehabilitation of the Brazilian Society of Cardiology has created a committee of experts to review the Portuguese version of the guideline and adapt it to the national reality.
The mission of this document is to help health professionals to adopt effective measures of CVDPR in the routine clinical practice. The publication of this document and its broad implementation will contribute to the goal of the World Health Organization (WHO), which is the reduction of worldwide cardiovascular mortality by 25% until 2025.
The study group's priorities are the following:
• Emphasize the important role of CVDPR as an instrument of secondary prevention with significant impact on cardiovascular morbidity and mortality;
• Join efforts for the knowledge on CVDPR, its dissemination, and adoption in most cardiovascular centers and institutes in South America, prioritizing the adoption of cardiovascular prevention methods that are comprehensive, practical, simple and which have a good cost/benefit ratio;
• Improve the education of health professionals and patients with education programs on the importance of CVDPR services, which are directly targeted at the health system, clinical staff, patients, and community leaders, with the aim of decreasing the barriers to CVDPR implementation.
I. INTRODUCTION
In the last 4 decades, CVDPR has been recognized as an important tool in the care of patients with cardiovascular disease (CVD). The role of the CVDPR services in the secondary prevention of cardiovascular events is recognized and accepted by all health organizations; however, the guidelines for CVDPR implementation have not yet been adapted to the needs and resources of Latin America. Therefore, the South American Society of Cardiology took the initiative of developing this guideline.
Justification for cardiovascular rehabilitation/secondary prevention
A preventive strategy for clinical practice should be developed on the basis of cardiovascular rehabilitation for the following reasons:
1. CVDs are the leading cause of death in most countries.
They are an important cause of physical incapacity and disability and contribute significantly to the increase in health costs;
2. Atherosclerosis can develop insidiously over decades and its clinical manifestations are only observed in advanced stages of the disease;
3. Most CVDs are closely associated with lifestyle as well as with physiological and biochemical factors;
4. CVDPR-promoted changes in the risk factors decrease the morbidity and mortality due to CVD, especially in individuals classified as high risk;
5. The prevalence of CVD and of risk factors, such as obesity, smoking, diabetes mellitus (DM), and systemic arterial hypertension has increased in the last decades;
6. Despite the known beneficial effect of CVDPR on patients with CVD, only 5%-30% patients eligible to participate in rehabilitation programs are referred to such programs. The percentage in Brazil is probably even lower;
7. Relatively few patients are referred to cardiovascular rehabilitation programs by physicians worldwide;
8. There are no specific CVDPR guidelines that contemplate the particularities of Latin American countries;
9. No certification programs for CVDPR services are available in Latin America till date.
The development of this guideline includes a detailed review of the various topics presented as well as a classification of the recommendations and evidence levels used (Table 1) .
Drafting committee
The drafting committee was nominated in March 2010 by the South American Society of Cardiology, in a joint work with the Mayo Clinic of Rochester, Minnesota, United States of America. This committee comprises 1 member from each of the following Societies of Cardiology in Latin America: Venezuela, Brazil, Argentina, Chile, Peru, Colombia, Uruguay, and Paraguay. In addition to these members, the committee relied on the cooperation of a group of specialists from the Mayo Clinic.
II. METHODOLOGY
Definition of cardiovascular rehabilitation/secondary prevention
According to WHO, cardiovascular rehabilitation is "the sum of the actions required to guarantee the best physical, psychological, and social conditions so that patients with CVD may maintain their role in society by their own efforts" 1 .
Eligibility criteria of patients for cardiovascular rehabilitation/secondary prevention
There is evidence that both formal exercise programs and increase in the levels of physical activity are associated with a marked reduction in mortality in individuals with and without coronary artery disease [2] [3] [4] [5] [6] . In a study conducted in Olmsted, Minnesota, with patients who participated in CVDPR programs, Roger et al. 7 observed a reduction of 25% in the rate of cardiovascular events for each metabolic equivalent (MET) increase in functional capacity. An increase of 1 mL·kg
in maximum oxygen consumption leads to a decrease in mortality of approximately 10% during an RCV program 8, 9 . The patients eligible for cardiovascular rehabilitation in the context of secondary prevention exhibited at least one of the following cardiovascular events in the past year: Table 1 
-Classification of recommendations and levels of evidence Recommendation classes
Class I: There is a general agreement that the method or procedure is beneficial, useful, and effective. A class I indication does not mean that the procedure is the only one acceptable Class II: There is difference of opinion regarding the justification and usefulness of the method or procedure. It is acceptable, but may be controversial Class IIa: The weight of evidence indicates usefulness or effectiveness Class IIb: The weight of evidence is not very well established regarding the usefulness or efficacy Class III: There is general agreement that the method or procedure is not indicated or justified. In some cases, it may even be dangerous
Levels of evidence
A: Solid evidence, from multiple randomized clinical trials or meta-analyses with adequate design to reach statistically significant conclusions B: Weak evidence, derived from a simple nonrandomized study or from several nonrandomized studies C: Expert opinion, small studies, or registries
• Acute myocardial infarction (AMI)/acute coronary syndrome (ACS)
• Coronary artery bypass grafting (CABG)
• Coronary angioplasty
• Stable angina
• Valve repair or replacement
• Heart or heart-lung transplantation
• Chronic heart failure
• Peripheral vascular disease
• Asymptomatic coronary artery disease
• Patients at high CVD risk O'Connor et al. performed a meta-analysis of 22 studies of CVDPR in post-AMI patients and observed a reduction in total mortality, cardiovascular mortality, and fatal AMI of 20%, 22%, and 25%, respectively 10 . In a study that involved 600,000 beneficiaries of the American Medicare system, Suaya et al. 11 observed that those who participated in a CVDPR program exhibited a reduction in mortality of 34% after a 5-year follow-up.
Patients ineligible for out-of-hospital cardiovascular rehabilitation
The contraindications for physical exercise in a cardiovascular rehabilitation program have been modified and are becoming increasingly complex. Although listed as absolute contraindications (Table 2) , several of these conditions may be deemed as temporary because after the stabilization of the acute phase, patients can initiate or resume regular exercise programs.
Objectives of cardiovascular rehabilitation
The pillars of cardiovascular rehabilitation and secondary prevention are as follows: lifestyle modifications with an emphasis on regular physical activity, adoption of healthy feeding habits, smoking and drug use cessation, and stress managing strategies. A CVDPR program should aim to improve the physiological and psychological status of cardiac patients and should be based on a multidisciplinary intervention (exercise program, education, clinical evaluation, nutritional evaluation, etc.).
Therefore, the objectives of cardiovascular rehabilitation are the following: 1) Assist patients with known CVDs or at high risk of developing them;
2) Rehabilitate patients in a comprehensive manner by offering physical, mental, social, vocational, and spiritual support;
3) Educate patients to adopt and maintain healthy habits through lifestyle modifications with or without pharmacological and/or surgical treatment; 4) Decrease disability and promote lifestyle modifications through the proactive engagement of patients in health promotion;
5) Improve quality of life; 6) Prevent new cardiovascular events; 7) Strictly control of risk factors.
For a CVDPR program to be successful, the interventions should be made in agreement with the health provider, the cardiologist, and/or family physician, to optimize and monitor long-term interventions.
III. DEVELOPMENT OF A CARDIOVASCULAR REHABILITATION PROGRAM
Risk stratification of patients referred to a cardiovascular rehabilitation program
To assess the potentials risks complications of exercise, patients should be stratified according to the classification proposed by the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) 12 (Table 3) .
Patients in the low-risk category can be monitored using electrocardiography (ECG) or Heart rate monitor during the first 6-18 sessions, preferably under clinical supervision. A gradual reduction in supervision between sessions 8 and 12 is desirable. Low-risk patients could also be referred to semi-supervised CVDPR programs or distance supervision, depending on their individual assessment.
Patients at intermediate risk should be monitored during the first 12-24 sessions, preferably by continuous ECG monitoring and permanent medical supervision, which should be decreased to intermittent monitoring after the last session. In addition, the monitoring frequency and methods adopted depend on the available resources, capacity of each institution, and patient status and progression 12 .
Greater supervision should be used for patients categorized as high risk and when changes in health status, new symptoms, or any other evidence of disease progression are observed. Monitoring can also be a useful strategy for assessing response to physical activity, especially when the intensity of aerobic exercise is increased.
Patient safety and monitoring
Potential cardiac complications during cardiovascular rehabilitation programs are as follows: cardiac arrest, arrhythmias, and AMI, among others (Table 4 ). The incidence of cardiac arrest is relatively low. According to studies conducted by Van Camp and Peterson 13 , with data from 167 American CVDPR programs involving 51,303 patients, more than 2 million hours of exercise were performed between 1980 and 1984. In this period, 21 patients sustained cardiac arrest, among which 18 patients were resuscitated and survived (only 3 cases were fatal) 13 . It is estimated that the rate of a major complication, such as cardiac arrest, death, or AMI, is 1 for every 60,000-80,000 h of supervised exercise 14 .
To achieve increased safety during physical exercise in a rehabilitation session, a comprehensive assessment of the patient is advised with the aim to define the level of CVD risk, individualized exercise programs, and adequate monitoring. Clinical supervision is the most important safety factor in CVDPR. A CVDPR specialist with experience in the management of complications should be present during each exercise session. In the absence of such specialist, the presence of staff qualified in emergency cardiopulmonary resuscitation is indicated. Of note, patients should be educated on self-assessment involving the presence of symptoms, perception of effort during exercise, well-being, risk limits, and immediate measures that should be adopted, such as informing the rehabilitation team about their symptoms, and stopping exercise 15, 16 .
The guidelines on clinical supervision of patients during secondary prevention programs remain to be a debated topic 12 . The level of clinical supervision is related to age, diagnosis, comorbidities in participants of rehabilitation programs, duration of recovery after the cardiovascular event, and the progression achieved during each session.
The number of sessions under ECG monitoring is not a measure of quality of the exercise program. This type of monitoring is a strategy adopted by each team according to a local protocol 12, 15 .
Components of the cardiovascular rehabilitation program
According to the guidelines of the American Heart Association (AHA), AACVPR, and the American College of Cardiology (AHA/AACVPR/ACC) 12 , a CVDPR program includes the comprehensive care of patients with CVD and chronic heart failure (class I evidence). CVDPR should include a consistent multidisciplinary approach, not only with regard to exercise but also to educational work aimed to control Table 5 .
Competencies of the Rehabilitation Staff
A CVDPR program is integrated by a multidisciplinary team (Table 6) , which requires the following competencies: basic knowledge in the cardiovascular, pulmonary, and musculoskeletal areas, ECG analysis, medical emergency management, and theoretical and practical knowledge regarding physical exercise. The core team is composed by physicians, nurses, and exercise specialists, with the option of including specialists from other disciplines to provide complete health care and education (nutritionists and psychologists, among others). The core team should have experience in the management of CVD risk factors, psychosocial assessment and intervention, and lifestyle changes.
Phases of cardiovascular rehabilitation
Numerous investigations have demonstrated the importance of early and progressive physical activity within a CVDPR program after an AMI or CABG. The program consists of 3 or 4 phases (Table 7) , depending on the different schools 12, 17 .
Initial patient evaluation
At the start of a rehabilitation program, the initial assessment of the patient must include obtaining an exhaustive and thorough medical history, which includes details regarding previous surgical procedures and comorbidities, such as cardiovascular, renal, pulmonary, and musculoskeletal diseases, as well as depression and other relevant information. During the initial evaluation, it is paramount to identify CVD risk factors, such as smoking, poor feeding habits, blood pressure (BP), Diabetes, dyslipidemia, obesity, physical inactivity, and stress. In addition to the information regarding medication use, it is important to assess the social, educational, and economic situation of the patient.
The physical examination will comprise a thorough assessment of the cardiovascular system, including BP, heart rate (HR), heart sounds and murmurs, palpation of peripheral pulses, and alterations in skin color; it will also identify musculoskeletal changes that may prevent inclusion in the program or restrict the execution of some exercises. The respiratory system examination will assess respiratory rate and presence or absence of abnormal sounds, which are characteristic of pulmonary pathologies 16, 18 . In patients with heart disease who perform regular physical activity, the following has been described: A "center" is considered to be a rehabilitation center when it features an area for physical activity, competent and trained staff, adequate equipment for physical exercises, equipment for emergency situations (basic and advanced life support equipment, with a defibrillator), and medical staff to address emergency situations. The center should also consider implementing management protocols for the rehabilitation of patients according to pathology.
Exercise prescription
Exercise prescription should always be considered individually in accordance with each phase, taking into account individual limitations and comorbidities (musculoskeletal, neurological, respiratory, renal, and among others).
Phase 1
During phase 1, in hospital, is a moment when patients are very receptive. In most cases, they are very vulnerable and open to new proposals for lifestyle changes. In addition to the exercises, which are always of low intensity and aiming for early movement, there is also an opportunity to educate the patients, by explaining about the disease and the importance of controlling the risk factors 19 . Exercises can be started immediately after disease stabilization:
• In cases of ACS, after the first 24-48 h, in the absence of symptoms;
• In cases of heart failure, after dyspnea improvement, gentle stretching and movement exercises can also be started as soon as the patient can ambulate;
• In cases of cardiac surgery, especially in the days prior to the intervention, a program comprising breathing exercises, stretching, and progressive movement, followed by physical therapy after surgery, provides a significant reduction in respiratory complications, arrhythmias, and length of hospitalization [19] [20] [21] .
Although it is difficult to generalize the recommendation, the patient should be assessed at the start of the exercise program at the hospital, to determine the best exercises for that phase, from passive to active exercises and low-intensity walking, which will be increased individually until hospital discharge.
Phase 2
In this phase, the patient needs supervision and individualized care, because this is the convalescence phase and the patient often has not had any previous contact with formal physical activities. Exercise prescription must include the type, intensity, duration, and frequency of exercises 22 . The duration of phase 2 varies between patients, lasting an average of 1-3 months 23 . Exercises should be initiated at a low intensity and low impact during the first few weeks, for initial adaptation and prevention of musculoskeletal injuries 24, 25 .
Aerobic exercise: Aerobic exercise intensity must fit the clinical picture, risk stratification, and patient's goals. Ideally, a stress test (treadmill test or cardiopulmonary exercise test) should be conducted to evaluate the ECG response, physical 
II (B)
Education
• Nutritional advice to the family and the patient, comprising:
• Weight control and modification of risk factors
• Abstinence from long-term smoking
• Achieve a BP < 130/80
• Control fasting glucose < 100 mg/dl
• In case of obesity, develop a strategy for weight reduction by at least 5%-10% of initial weight • Diet I (C)
Human Resources:
Qualified cardiologist or exercise physician
• Directs the program and prescribes the safety limits of the exercise; assesses the patient and obtains the clinical history. Conducts the stress test.
• It is important that each CVDPR program has a specialized and committed staff capacity, HR and BP response to stress, thus allowing for a better individualized prescription of physical exercise intensity. In order to avoid delaying of rehabilitation program, just after the medical release, the initial assessment can be made by the physical therapist or physical education professional in the first sessions, adapting the exercise prescription until the stress test is avalable 22 .
The intensity of aerobic exercises, which aim greater benefits to the cardiovascular system and metabolism, has been the object of investigations 26 . High-intensity exercises are more effective in improving insulin resistance, BP reduction, and promoting a greater weight reduction when compared with moderate-intensity exercises 27, 28 .
If the stress test is available, the target exercise heart rate should be around the anaerobic threshold. In the case of stress test without expired gas analysis, the target is 60%-80% of maximum HR (MHR), or 50%-70% of resting HR (RHR). In the first sessions, exercises are suggested to be performed in the lower limit of the prescription, progressively increasing according to the individuals' response and progress. Moreover, exercises should be performed below the ischemic threshold, i.e., below HR and load that induce clinical and ECG signs of myocardial ischemia during stress.
The exercise duration must be of at least 30 min, progressing to 1 h of continuous or intermittent exercise. The frequency can be 2-5 times/week, with an average of 3 times.
Resistance exercises: Muscle strengthening exercises should be started gradually with light loads, progressing throughout the sessions 12, 22 . At this stage, the objective is to familiarize the patients with the exercises, ensuring that they are executed with correct posture and gradual progression of the load. They can be performed 2-3 times/week, with 6-15 repetitions per muscle group, at intervals of 30 s to 1 min.
Flexibility exercises: They are also known as stretching. They must be carried out progressively and without discomfort, always respecting musculoskeletal limitations. They can be performed at the beginning and, especially, at the end of rehabilitation sessions 29 .
Phases 3 and 4
These phases have an indefinite duration 23 . The main difference between them is that phase 4 is performed by long-distance supervision, also known as rehabilitation without supervision. In essence, the prescription of these 2 phases is very similar, because the prescribed exercises are part of daily life. The prescription must be updated periodically and adapted to the profile and comorbidities of each patient. A reassessment, which can be repeated every 6-12 months, is preferred when initiating the third phase.
Aerobic exercise:
In asymptomatic patients, training HR should be 70%-90% of MHR achieved in the stress test, or 50%-80% of RHR, or between the first and the second threshold obtained during the cardiopulmonary test.
These exercises are also performed below the ischemic threshold, i.e., below HR and load that induce clinical and ECG signs of myocardial ischemia during stress. In selected cases of patients with symptoms, such as stable angina, MHR can be just below that at which symptoms appear, even if ECG shows indirect signs of ischemia.
Resistance exercises: They should be performed in sets of 8-15 repetitions, with progressive loads sufficient to cause fatigue in the last 3 repetitions, but without causing physical breakdown. Ideally, they should be performed 3 times/week. As an alternative to conventional exercise with free weights or weight machines, the Pilates method with practical resistance can be used in combination with flexibility and breathing exercises 12, 30 .
Flexibility exercises should be a part of gym classes, either at the beginning and/or, preferably, at the end of each session. A combination of practices, such as yoga, tai chi, can be adopted; these practices help decrease BP 31 and increase maximum oxygen consumption 32 .
Balance exercises: They are essential; they should be performed 2-3 times/week, especially by the elderly population, to maintain self-sufficiency in this age group and help prevent fractures due to falls 13 .
Components of the exercise
The training program should take into account the following points:
• Training frequency: It should be at least 3 times/ week. Ideally, the patient should be encouraged to perform daily physical activity (walking, climbing stairs, cycling) 12, 22 .
• Duration of each session: The recommended duration is 40-60 min/day.
• Training intensity: This can be controlled by the training HR (THR). In this strategy, the goal is to perform the prescribed exercises at the heart rate between the two respiratory thresholds or 70%-90% of MHR obtained during the stress test. Another common practice is the use of RHR by applying the Karvonen formula (50%-80% of RHR) 33, 34 .
Karvonen formula: THR = RHR + (0.5−0.
8) × (MHR − RHR)
The patient's subjective perception of exertion should always be assessed, using the Borg scale of perceived exertion 35 [Rating Perceived Exertion (RPE)] (Table 8) .
Subjectively, the speech test can also be used, in which patients are aware of their own respiratory movements, i.e., the exercises are performed at an intensity that leads to a heavier breathing, without reaching a degree of tachypnea that prevents the patient from completing a sentence.
• Specificity of training: in some cases, the patients' training should consider the muscle groups that they usually use in Table 6 -Human resources competences in a cardiovascular rehabilitation program
Human resources Competence
Medical director their day-to-day activities, thus generating greater muscle strength for daily work 12, 25 .
Components of each session a) Warm-up period: a moment in which muscle groups are incorporated gradually; starting with small groups and then progressing to larger muscle groups. Initially, the exercises are performed slowly; the repetitions and the speed increase progressively. After approximately 5 min, a more intense warm-up session starts, including jogging or another higher-intensity exercise (lasting 1-3 min). In general, when a patient begins rehabilitation, the warm-up period is longer. Before the first session, it is desirable that some testing is performed. The aim of the examination (such as the 6-min walk test) is to enable an objective analysis of the current state of the patient 12, 29, 36, 37 .
b) Exercise training:
It can be performed with a bicycle ergometer, treadmill, climber, or simply consist of a walk/jog guided by trained personnel. Usually, the duration of training is short (15 min) in the first session, with weekly or per-session progression, depending on the case. This phase should be connected with the time and intensity of exercise.
THR is determined according to the prescription method and/or results of the stress test, as previously discussed. The goal is to achieve and maintain this HR during the execution of continuous or interval aerobic exercise. Furthermore, it is convenient to add resistance exercises to every session 12 .
c) Cool-down period: All sessions must take into account that the patient should return to the initial HR and BP levels in the last minutes of the session. The methods used to achieve this goal are varied, but some elements must be present, such as gradually decreasing the load of aerobic exercise, stretching, resting on a chair or mattress, and using breathing techniques (abdominal breathing) 12, 29 .
Types of exercise
The exercises can be divided into isotonic or dynamic and isometric or static:
• Isotonic or dynamic exercises change muscle length with rhythmic contractions, joint movements, and limited strength development. These exercises cause a significant increase in oxygen consumption, systolic volume, and HR. The systolic BP (SBP) increases and the diastolic BP (DBP) may decrease as a consequence of the reduction in total peripheral resistance 16 .
• Isometric or static exercises cause an increase in muscle strength with little change in muscle length. During these exercises, SBP increases significantly, and HR and systolic volume increase less than during dynamic exercise 16 .
However, the majority of activities present a combination of these 2 types of exercises in varying magnitudes; the hemodynamic response depends on which is performed with greater intensity.
With regard to the types of training: the most relevant are continuous and
• Continuous training: It relies on a steady exertion over a given time. Preferably, it is of moderate intensity, to last longer. It usually comprises a walk or run at a moderate and constant intensity, and the speed of execution and the behavior of cardiopulmonary variables depend on the clinical presentation and individual physical capacity. The minimum suggested time to maintain this type of effort is 20-30 min/session 38, 39 . It may be performed at different intensities (Table 9 ).
• Interval training: it is defined as an exercise or a series of exercises composed of periods of exertion that alternate with periods of active or passive recovery. When the exercise is of high or moderate intensity, active intervals are used, using either the same or different exercises, but of lower intensity 40 . If the patient's functional capacity is low, passive recovery intervals can be used. In such patients, this training method with alternating loads may be the only way to start an exercise program, because of the low tolerance to continuous loads. The progression is made by gradually increasing the periods of activity and decreasing the resting periods, or by replacing them with lower-intensity activity (active recovery). Before starting this activity, a longer warm-up session is needed, as well as a low-intensity recovery at the end of the session 38 .
Education
As previously mentioned, a multidisciplinary CVDPR program includes not only the scheduled exercise plan but also the education provide to the patient, about CVD and the appropriate management of risk factors 12 .
Obesity and overweight
Definition and facts
The incidence and prevalence of overweight and obesity have increased globally to alarming levels. Obesity is considered a worldwide epidemic, both in children and in adults, affecting nearly one-third of the world's population. According to the INTERHEART study, the most prevalent CVD risk factor is abdominal obesity, whose prevalence is 48.6% in Latin America, compared with 31.2% in other participating countries 41 . The consumption of high-calorie foods, rich in simple carbohydrates and saturated fats, associated with physical inactivity, are responsible for this worldwide epidemic.
The increase in adiposity is associated with the increase in free fatty acids, hyperinsulinemia, insulin resistance, .
Although BMI is a simple method to detect individuals with considerably increased body fat, particularly in population studies, recent studies have questioned its validity in diagnosing individual obesity [44] [45] [46] . Numerous studies have demonstrated that central obesity measures correlate better with CVD risk than BMI 47 . Therefore, it is more important to determine whether there is an increase in abdominal fat than to define body weight in relation to height. A simple way to determine this is by measuring the perimeter of the waist with a tape measure, either at the navel level or 2.5 cm above the iliac crest. The cutoff points recommended for diagnosing central obesity, using waist circumference, are ≥ 94 cm for men and ≥ 80 cm for women. If the waist-hip ratio values are used for diagnosing central obesity, the cutoff points are as follows: ≥ 0.9 for men and ≥ 0.85 for women. All these calculations have been established for Caucasian individuals. Other parameters and other determinations are necessary for the various Latin American ethnic groups 48, 49 .
Other methods used to measure body fat are computed tomography, ultrasonography, magnetic resonance imaging, and whole-body air displacement plethysmography. Waist circumference measurement has the advantage of being a simple method and of being superior to BMI; however, it should be noted that this method is prone to measurement errors [48] [49] [50] .
Challenges and goals
Weight reduction is recommended in patients with obesity (BMI ≥ 30 kg/m Values between 94 and 101 cm for men and between 80 and 87 cm for women should be considered as an alert; they represent a threshold from which one should not gain more weight. Restriction of total caloric intake and regular exercise are the cornerstones of weight control. It is likely that exercise will produce improvements in the metabolism of central adiposity, even before weight reduction is noticed.
Special recommendations
Feeding habits education is paramount, with emphasis on decreasing caloric intake and drastically decreasing the intake of fats and simple carbohydrates. The patient should be encouraged to consume more fruit, vegetables, whole-grain foods, and monounsaturated and polyunsaturated fats. The habit of mild-to-moderate alcohol consumption should not be discouraged; however, this area of knowledge still requires further studies to define the best conduct.
The frequency, duration, intensity, and volume of exercise performed must be adapted to the physical fitness level of the individual. Prolonged exercises at a moderate intensity are preferred, although the program should be initiated at a light intensity and progress as results are achieved. The best exercises are dynamic exercises, which employ large muscle groups and are predominantly aerobic.
Sedentary lifestyle
Definition and facts
The percentage of sedentary population in Latin America oscillates between 25% and 75%; this very wide range is because of the differences between the studies carried out in each region. Individuals who remain sedentary are at a higher risk of death and at a 2-fold higher CVD risk when compared with their physically active peers 51 .
Challenges and goals
• To initiate, recondition, and educate the patient regarding exercise prescription;
• To motivate the patient to continue the practice of physical activity indefinitely (30-60 min of moderate exercise, 5 -7 days/week) (class I, level of evidence B);
• To ensure that all members of the CVDPR programs know, educate, and motivate patients to perform physical activities according to the prescription. 
Special recommendations
• To collect a complete medical history;
• To determine the CVD risk individually;
• To prescribe physical activity (aerobic, resistance, and flexibility);
• To supervise the physical activity practice according to the risks and prescriptions.
(Refer to the section Exercise for more details regarding the recommendations and exercise prescriptions.)
Psychosocial stress and depression
Definition and facts
Stress has been defined as a "situation of an individual or of any of his/her organs or systems that, by requiring a greater performance than normal, places the individual at risk of becoming ill." It is a body's response or reaction that requires adaptations, which may be acute or chronic 52 . These adaptations are not always well tolerated or accepted. All these adaptations include anxiety, emotional exhaustion, depersonalization, emotional insecurity, fear of failure, chronic job stress, personality traits, character, and social isolation, which lead to depression. Elevated stress is clearly associated with AMI. Nowadays, stress is considered a risk factor as important as hypertension, smoking , and dyslipidemia.
Unfortunately, there are not enough data to know with certainty the prevalence of increased stress, depression, and other psychosocial problems in Latin America. Data from the INTERHEART study demonstrate that in Latin America the prevalence of chronic stress and depression is, respectively, 6.8% and 36.7% 41 .
Stress responses produce increased autonomic activity by the activation of the sympathetic nervous system and catecholamine release, causing an increase in HR, contractility, minute volume, and peripheral vascular resistance, as well as inhibiting insulin secretion and increasing the release of hepatic glucose and fatty acids into the blood stream. Concurrently, there is an increase in platelet aggregation and a decrease in the ventricular fibrillation threshold 52 .
Challenges and goals
It is important to know the degree of stress and depression of patients seeking a CVDPR program; the use of standardized questionnaires is recommended, such as the PHQ-9 depression questionnaire, which is free and available online. Once the patient's condition is known, he/she should be severity of the emotional problem.
Special recommendations
The recommendations focus on the identification of these groups of patients to allow early intervention, through psychotherapy and lifestyle changes, not only aimed specifically at the individual but also at the family members. These measures may include group therapy, specific medication, physical activity, and social support, which are all administered by specialized professionals 53 (class I, level of evidence B).
Smoking Definition and facts
Smoking is a chronic addiction caused by the excessive tobacco smoking, which is triggered by its main component, nicotine. It is an independent risk factor for CVD 54 , and is regarded as a leading cause of preventable deaths worldwide 55 .
According to WHO, a smoker is a person who has had this habit daily for the previous month, regardless of the number of cigarettes smoked. A passive smoker is defined as a person who is exposed to tobacco smoke in its different forms, such as pipes and cigarettes. There is no minimum innocuous exposure to cigarette smoke: passive smoking increases the CVD risk by 25%-30% 56 .
There have been significant changes in the implementation of smoke-free areas, through a historic partnership between WHO and Latin America and Caribbean countries 57 . The prevalence of smoking in this region is approximately 31% in men and 17% in women, which motivates physicians to work toward improving this situation 58 .
Challenges and goals
The overall goal is to achieve complete cessation of cigarette smoking 59, 60 . For achieving such a goal, CVDPR and secondary prevention programs should include comprehensive smoking cessation measures; they should also educate the smoker by promoting and implementing public health measures related to the suppression of the habit 56 (IB).
Specific recommendations
Every clinical history must include questions regarding smoking history, so as to diagnose smokers according to the above definition. It is also necessary to check whether there is environmental exposure and whether the patient wants to quit smoking, as well as measure physical dependence, and prepare a smoking cessation plan that includes follow-up and feedback 59, 60 .
Some useful recommendations regarding smoking are as follows:
• To routinely apply questionnaires on smoking habits;
• To indicate the amount of tobacco consumed and attempts to stop smoking;
• To assess the patient according to physical, psychological, social, and gestural addiction, as well as nicotine dependence (Fagerstrom test, Glover and Nilson test) 61 ;
• To identify the phase of interest in smoking cessation according to the criteria by Prochazka and DiClemente (Precontemplation, Contemplation, Preparation, Action, Maintenance) 62 ;
• To establish a conversation to generate awareness (IA);
• To follow the smoking cessation process ("5As"): Ask about smoking status; Advise to quit; Assess willingness to stop smoking; Assist in smoking cessation; and Arrange follow-up consultation 63 ;
• To offer help regardless of patient motivation 64 ;
• To create interventions that enables the patient to advance in the stages of interest in smoking cessation;
• To offer and refer to pharmacological therapies for smoking cessation (nicotine replacement, bupropion, varenicline, and/or combinations thereof) 65 . Although the use of medications to help in smoking cessation has been used in cardiovascular patients, their prescription should be left to the cardiologist; The scope of smoking cessation management in CVDPR programs is an opportunity for the other the members of the household. Thus, this approach can prevent the onset of cigarette smoking (children, grandchildren, siblings, other family members) and/or its complete eradication in the nuclear family (IB).
Dyslipidemia
Definitions and facts
Dyslipidemia is a major risk factor for developing atherosclerosis. Every 1% reduction in low-density lipoprotein cholesterol levels (LDL-C) translates into a reduction of 1% in the risk of future cardiovascular events. A 1% increase in high-density lipoprotein cholesterol levels (HDL-C) is associated with a risk reduction of 2%-4% 41 . The prevalence of dyslipidemia in Latin America is 42%, according to the INTERHEART study, compared with a 32% prevalence in other countries participating in that study 41 .
Challenges and goals
Risk stratification:
The Adult Treatment Panel III (ATP III) 66 guidelines for dyslipidemia treatment in adults defines the classification of LDL-C, HDL-C, and total cholesterol levels according to their plasma levels (Table 10) . That document also identified LDL-C as the main treatment target (class I, level of evidence A).
The ATP III established risk categories according to the presence or absence of other risk factors. The presence of CVD or other clinical forms of atherosclerosis, the so-called risk categories, determine the LDL-C target (Table 11) .
It remains to be determined whether the LDL-C targets in primary prevention will remain the same, given the results of the Jupiter study 67 , which randomized to treatment with rosuvastatin or placebo patients without coronary artery disease who had LDL-C < 130 mg/dl and high-sensitivity C-reactive protein levels > 2 mg/l. The study was completed ahead of time, having shown a clear benefit in favor of the group treated with rosuvastatin, which exhibited a 44% reduction in the primary outcome (combined endpoint) of cardiovascular death, nonfatal stroke, nonfatal AMI, unstable angina, or CABG.
Special considerations
As previously mentioned, the overall risk stratification defines each patient's LDL-C targets according to the risk category. To achieve these goals, treatment must often be aggressive. The therapeutic options are as follows:
• Nonpharmacological measures: decreased intake of simple carbohydrates and of saturated and trans fats in general; weight loss in individuals with obesity; and increased physical activity (class I, level of evidence B). Aerobic exercise of moderate intensity is considered to have the greatest impact on triglyceride levels and to have less impact on HDL-C, and even less impact on LDL-C 66 .
• Pharmacological measures: the primary goal in dyslipidemia management is to achieve a reduction in LDL-C in accordance with the goals described in Table 11 . Statins are the most commonly used drugs because of their impact on risk reduction. In addition to these drugs, niacin, fibrates, resins, and ezetimibe may be used 66 .
Other treatment goals:
• If triglyceride levels are between 200-499 mg/dl after the LDL-C target has been reached, medication can be used to achieve the non-HDL-C target (class I, level of evidence B), which must be less than the LDL-C + 30. This can be achieved by intensifying statin therapy and adding nicotinic acid or fibrates 66 . If triglyceride levels are > 500 mg/dl, the priority should be to decrease this level to decrease pancreatitis risk (class I, level of evidence C).
• Another important goal is to increase HDL-C, particularly in patients with extremely low HDL-C and atherosclerotic CVD. Niacin can be used; it should be started at a low dose (500 mg) and increased according to tolerance (up to a maximum dose of 2 g). Statins also increase HDL-C, but to a lesser extent 66 . The evidence supporting the use of drugs to increase HDL-C is not strong, and recent studies have questioned the use of niacin for this purpose, whereas others have demonstrated that the use of cholesteryl ester transfer protein inhibitors to increase HDL-C may increase cardiovascular mortality 68 .
Arterial hypertension
Definitions and facts
One of the most common problems in primary care is the lack of detection, treatment, and control of hypertension, which is undoubtedly a risk factor with the highest impact in CVD.
The worldwide prevalence is approximately 1 billion individuals, causing approximately 7.1 million deaths per year 69 . In Latin America, 13% deaths can be attributed to systemic arterial hypertension. According to the Interheart 41 study, the prevalence of systemic arterial hypertension in Latin America is 29.1%, higher than the 20.8% observed in other participating countries. Another problem is that approximately 30% adults are unaware that they have this disease. More than 40% hypertensive patients are untreated, and two-thirds do not have controlled BP (> 140/90 mmHg). Table 12 presents the classification of systemic arterial hypertension according to the guidelines of the Seventh Report of the Joint National Committee (JNC VII) for adults 69 . The classification is based on the average of ≥ 2 BP measurements, performed in the sitting position in ≥ 2 visits.
Classification of BP
Challenges and goals
The treatment goal for hypertensive patients without other disorders is BP < 140/90 mmHg (class I, level of evidence A). In hypertensive patients with renal disease or DM, the BP target is < 130/80 mmHg; however, recent studies have shown that it is probably not crucial to achieve such levels to decrease the CVD risk, particularly in patients with DM 70 .
Specific recommendations
To achieve the treatment goals, it is crucial to implement lifestyle changes (Table 13) . Such approaches should also be recommended to normotensive patients with genetic predisposition for hypertension (e.g., both parents aged < 60 years medicated for systemic arterial hypertension).
With regard to physical activities, those with a predominance of dynamic components are ideal. Their benefits become apparent after the third week after exercise initiation. Muscle strength exercises have not shown benefits in hypertension as an isolated method, because they must be performed together with dynamic exercises (class I, level of evidence B) 69 .
With regard to drug treatment, a reduction in BP should be considered as the target of the pharmacological treatment, regardless of the medication used. As is usual in cardiovascular prevention, the decision to start the drug treatment depends on the patient's overall risk. Because the majority of hypertensive patients require ≥ 2 antihypertensive drugs to achieve BP control, the addition of a second drug from a different class should be indicated when BP is > 20 mmHg above the target SBP or > 10 mmHg above the DBP target despite the use of a single agent at suitable doses 69 .
Diabetes
Definition and facts
DM is a metabolic disorder of multiple etiologies characterized by chronic hyperglycemia with disturbances in the metabolism of carbohydrates, fats, and proteins, which results in defects in insulin secretion and/or action.
The main cause of death in individuals with type 2 DM is cardiovascular; therefore, preventing CVD involves an integrated management of all risk factors. All CVD risk factors (except smoking) are more common in individuals with diabetes, and their impact on CVD is also higher 72 . Approximately 25.1 million individuals have type 2 DM, representing 8.7% adult population in Latin America, according to the 2011 census. It is estimated that this figure will reach approximately 40 million people (60% of the adult population) in the next 20 years. Moreover, it is important to mention that currently 15.1 million people (5.2% of the adult population) suffer from glucose intolerance, a situation that should be considered as a warning and trigger more efficient measures for DM prevention (International Diabetes Federation).
For the diagnosis of DM, according to the American Diabetes Association (ADA) 73 , any of the following criteria can be used:
1. Glycated hemoglobin levels (HbA1c) ≥ 6.5.
2. DM symptoms combined with blood glucose levels, measured in venous plasma, ≥ 200 mg/dl (11.1 mmol/l).
3. Fasting glucose ≥ 126 mg/dl (7 mmol/l).
Glucose levels, measured in venous plasma, ≥ 200 mg/dl (11.1 mmol/l) 2 h after a glucose load, during an oral glucose tolerance test (OGTT).
For diagnosis in an asymptomatic individual, it is essential to have at least 1 positive blood glucose result equal to or greater than the levels in items 3 and 4.
Challenges and goals
Strict glycemic control (class I, level of evidence A) (Table 14) 75 demonstrated a linear relationship between stable HbA1c and the risk of complications, although the level at which the risk disappears was not identified. Currently, the therapeutic goal of HbA1c is < 8%, and < 7% in young CVD patients. The ACCORD study demonstrated that, in patients with type 2 DM, there is no additional benefit in decreasing HbA1c to strict low levels (< 6.5%) and that, on the contrary, this reduction could increase mortality 76 .
Specific recommendations
DM treatment includes pharmacological and nonpharmacological measures. Nonpharmacological measures include 3 basic aspects: diet strategies, exercise, and healthy habits 12 . Weight reduction in obese patients with DM remains the only comprehensive treatment that can simultaneously control most metabolic problems from type 2 DM (class I, level of evidence C). Pharmacological treatment should be initiated in every person with type 2 DM who has not achieved control of blood glucose levels through therapeutic lifestyle changes.
Refer to the Special Populations section for additional recommendations for cardiac rehabilitation in individuals with diabetes. 
Metabolic syndrome
Definition and facts
Metabolic syndrome is a cluster of risk factors that include central obesity, elevated BP, elevated levels of triglycerides and blood glucose, and low HDL-C (Table 15 ). The pathophysiology of this syndrome is insulin resistance. This means that glucose metabolism at the cellular level is altered, and a higher amount of insulin becomes necessary to metabolize the same amount of glucose. That is, there is a decreased sensitivity of the peripheral tissues, particularly skeletal muscle, to insulin action, thus producing secondary hyperinsulinemia. Patients with this syndrome are at twice the risk of suffering a cardiovascular event and at 5 times DM risk 78, 79 . In addition to the described metabolic abnormalities, it has been demonstrated that this syndrome is accompanied by an increase in plasminogen activator inhibitor (PAI-1), which potentially increases thrombogenesis, and is therefore another element that adds to AMI risk 66, 80 .
Challenges and goals
• To achieve the proposed goals for each component of the syndrome;
• To measure waist circumference in all patients;
• To educate the patient about the strong influence that a lifestyle change can have on this syndrome.
Special recommendations
• To decrease body weight;
• To decrease waist circumference;
• To perform predominantly aerobic exercise of moderate intensity, aiming to reach 80 to 90% of MHR (stress test), as well as resistance exercise with frequent repetitions and sets that exercise various muscle groups;
• To decreased added sugar intake, as well as sweetened beverages, and simple carbohydrates.
Recommendations on restarting sexual activity after cardiovascular events
Lack of confidence to perform sexual activity, decreased libido, erectile dysfunction, and ejaculation disorders are important points to consider after a cardiovascular event. Orientation and therapeutic management should begin from the earliest stages of CVDPR programs 81 . Some practical recommendations 82 
:
• If the patient is able to achieve 6 METs of physical exertion in a stress test, or the equivalent in daily life tasks, sexual activity should not be restricted, because neither the duration nor the intensity of physical effort during sexual activity are risky enough to cause cardiovascular complications.
• It is advisable to prevent excessive consumption of food and alcohol a few hours prior to sexual activity.
• It is recommended to indulge in sexual activity in an appropriate manner, in which the patient feels relaxed and willing to indulge in the activity. Moreover, it is advisable to adopt positions that do not demand an excessive effort from the patient. The patient needs to be aware that the majority of MIs related to sexual activity appear to occur in situations of infidelity and/or in concomitant use of drugs, or when patients are experiencing high stress.
• Counseling is key in restoring the patient's confidence.
• The use of sildenafil and other phosphodiesterase inhibitors is not contraindicated in CVD patients, unless they have class IV angina, severe valvular stenosis, or persistent ventricular arrhythmias. Such drugs are also contraindicated when the patient uses nitroglycerin or other nitrates regularly.
IV. CARDIOVASCULAR REHABILITATION IN SPECIAL POPULATIONS
Rehabilitation in adults aged <55 years
Definition and facts
The pathologies that lead to CVDPR indication in this group of patients comprise, mostly, coronary artery disease (after AMI, CABG, angioplasty, medical management of coronary artery disease, followed by valvular heart disease, heart failure, and congenital heart disease).
This age group has its own characteristics, which require additional specific recommendations, together with those described for each of the abovementioned conditions. Such characteristics include the fact that this group is more likely to be economically active, performing activities that may require significant physical effort; more likely to have children at home, with the responsibilities that this entails; and a high probability that income is decreased during the acute episode. All these factors create major barriers to both access to and permanence in a CVDPR program, as well as difficulties in adhering to healthy habits and pharmacotherapy in general 83 .
Challenges and goals
• Decrease the access barriers to CVDPR programs;
• Promote and encourage strategies that improve CVDPR program adherence;
• Implement strategies that educate the patients regarding healthy habits, exercise prescription, and the importance of medication 12, 25 .
Specific recommendations
The recommendations within the CVDPR program are the same as those for every pathology 12 .
Rehabilitation in the elderly
Definition and facts
The elderly, defined as those aged >65 years, are often excluded from CVDPR programs; however, there are known benefits from the improvement in functional capacity, quality of life, and modification of risk factors in this age group 84 . This population has a decreased level of physical capacity, decreased flexibility, and exhibits alteration of the senses and impaired balance. In this scenario, the implementation of specific recommendations has a fundamental role 85, 86 .
Challenges and goals
• Encourage the referral of the elderly to CVDPR programs;
• Minimize barriers to inclusion and adherence to the program;
• Manage comorbidities in a comprehensive manner;
• Achieve a higher level of independence, self-care, and social adaptation;
• Stimulate the practice of resistance exercises to prevent or reverse sarcopenia;
• Consider the possibility of some cognitive deterioration that can represent a challenge in learning exercise techniques, diet, and other principles included in the CVDPR program.
Specific recommendations
• Encourage learning motivation, not only in the context of exercise but also regarding information related to their illness;
• Consider whether orders, indications, and precautions should be repeated;
• Include exercises that promote self-care;
• Combine aerobic exercise with individualized exercise program and stretching, flexibility, coordination, and balance exercises. Prescribe resistance exercises with low load 87 and multiple repetitions, covering various muscle groups.
Rehabilitation in children and adolescents
Definitions and facts
Pathologies with CVDPR indication in this population derive from congenital heart disease, with or without heart failure, as well as neurocardiogenic syncope. There is evidence that regular physical activity can be beneficial, even in children with complex congenital heart disease, resulting in significant changes in functional ability, behavior, self-care, and emotional state 87, 88 .
Challenges and goals
• Minimize barriers to inclusion for this group of patients;
• Consider the educational component related to healthy habits;
• Achieve the highest level of patient's self-care and adaptation to the family and social context.
Specific recommendations
• Guide and motivate patients to perform their preferred recreational physical activity that meets the specific recommendations for each pathology and clinical status;
• Dietary recommendations should consider the patient's age and developmental stage, as well as the underlying disease; thus, it is very important to include consulting and monitoring by nutrition experts.
Rehabilitation in women
Definition and facts
There is limited specific information on women, because they are under-represented in clinical trials.
The current CVDPR recommendation for women in secondary prevention is class I, level of evidence A (women with recent acute coronary event, coronary intervention, or CVD) 89 .
In most Latin American countries, CVD is a major cause of morbidity; however, it is recognized that, on average, < 10% of the total participants in CVDPR programs are women 90, 91 .
With regard to risk factors for coronary artery disease, there are some characteristics that can differ according to gender, such as physical inactivity, stress, and diabetes. It is known that women initiate CVDPR programs at an older age (an average of 10 years more), present higher anxiety than men, and are physically less fit; they also have more comorbidities and worse quality of life. In general, the benefits of CVDPR programs for women are the same as those for men, although some studies suggest that the former benefit from a greater impact of quality of life functional class. Despite this fact, women are less likely to stay in the program than men 92 .
Challenges and goals
• Increase the participation of women with CVD in CVDPR programs;
• Increase the permanence of women in CVDPR programs;
• Maintain healthy habits after the end of the CVDPR program.
Specific recommendations
The current recommendation for physical activity for women is 30 min/day, 5-7 days/week, increasing to 60-90 min of moderate activity in most days of the week. The exercise program should include strength, balance, coordination, flexibility, and stretching activities (class I, level of evidence B).
Furthermore, it is important to:
• Adjust the exercise prescription to the comorbidities of the patient;
• Include the patient in a compatible physical activity group;
• Consider the atypical symptoms that may be present;
• During the sessions, determine the patient's preferred type of aerobic exercise (walking, dancing, cycling, swimming, or other), thereby favoring its performance as a part of the patient's routine, independently of the program 87 .
Rehabilitation in patients with DM
Definition and facts
Proper diagnosis and treatment of DM are associated with decreased mortality. Part of the treatment is physical exercise, which should be adequately performed, with the attention that these patients require. Therefore, the interdisciplinary group in a CVDPR program must be aware of the correct approach in patients with this disease 93, 94 .
Challenges and goals
These are the goals of CVDPR staff:
• Know the medical history of the patient with diabetes, considering the following:
-The presence of CVD;
-The presence of comorbidities, retinopathy, neuropathy, and nephropathy;
-The results of recent tests (fasting glucose level, OGTT, HbA1c, ophthalmic examination, lipid profile, etc.);
-The patient's current medication, with special attention to medications that cause hypoglycemia 95 (Table 16 ). If the patient is being treated with insulin, the staff should know the type, dose, and route of administration.
• Know the patient's history of hypoglycemia: frequency, associated circumstances that may contribute to its onset, symptoms, prior hypoglycemia (use of carbohydrates) 95, 96 . Each center should create their own protocols for glucose monitoring and develop appropriate policies and procedures, tailored to their institution;
• Know the use of glycemic self-monitoring: frequency and time of day, interpretation of results, and treatment if necessary 95 ;
• Educate patients regarding foot care: the patient must be advised on proper feet hygiene and on the importance of using comfortable shoes to avoid friction, wounds, burns, and injuries that may complicate his/her condition 96 .
Special recommendations Exercise prescription:
The exercise must comply with the following goals:
• Short term: change the sedentary habits through daily walks at the patient's pace.
• Medium term: the minimum frequency should be 3 times/week on alternate days, with a minimum duration of 30 min/session.
• Long term: increase the frequency, if possible daily, and with moderate intensity, 45-60 min in duration, following the warm-up, exercise, and cool-down stages. Aerobic exercise (walking, jogging, swimming, cycling, among others) is recommended 92 .
The practice of high-intensity exercise or competitive sports requires preventive measures, such as:
• Assessment of cardiovascular status in patients aged >30 years or who have had DM for > 10 years (there is a greater risk in case of proliferative retinopathy, autonomic neuropathy, and others).
• Avoid high-intensity exercise if there is evidence of proliferative retinopathy.
• Insulin-dependent patients should consume a meal or a snack rich in complex carbohydrates before starting physical activity, and they should have a sugary drink at their disposal because of the risk of hypoglycemia. Eventually, the physician will indicate an adjustment of the insulin dose for exercise days.
• High-risk exercises, in which the patient cannot receive immediate aid (climbing, hang gliding, scuba diving, among others), are not recommended.
Controlling glucose levels during CVDPR sessions
There is no consensus regarding the frequency or the indication of glucose monitoring prior, during, or after a CVDPR session. However, glycemic control is useful during the first sessions to determine the glycemic response to exercise. Thus, it is possible to successfully prevent hypoglycemia and properly adjust the exercise prescription to each patient, by defining whether prior or subsequent self-monitoring in each session is required. If the monitoring of post-exercise glucose is necessary, it should be performed 15 min after the end of the session. If the blood glucose level obtained in the first sessions is < 100 mg/dl or > 300 mg/dl, the physician should be informed, so that he/she can prescribe the treatment deemed appropriate for the patient. Patients who use insulin or oral hypoglycemic agents that may cause hypoglycemia should maintain blood glucose levels >100 mg/dl prior to exercise.
In case of hypoglycemia:
• Administer 15 g of carbohydrates to the patient (e.g., a fruit, a glass of sugary drink, sweetened juice, or a cup of milk). Assess the patient 15 min after carbohydrate ingestion.
In case of hyperglycemia:
• Type 1 DM patients with fasting blood glucose >300 mg/dl and ketosis should discontinue exercise, because it can aggravate ketosis. It is not necessary to suspend exercise, based simply on hyperglycemia, in cases of negative ketosis.
• Type 2 DM patients with fasting blood glucose >300 mg/dl can perform physical activities, but with caution. Table 17 presents the recommendations and key points for the management of patients with diabetes.
Rehabilitation in patients with heart failure
Definition and facts
Heart failure is a major health problem, especially in the elderly population 85 . Although the primary pathology of heart failure results from abnormalities in cardiovascular function, changes in peripheral blood flow, metabolism, and skeletal muscle morphology (in its strength and endurance) contribute largely to the symptoms (peripheral flow).
The results of systematic studies indicate that regular exercise in patients with heart failure is safe and is associated with an increase in peak oxygen consumption by 16%. With regard to central hemodynamic mechanisms, patients who enter a CVDPR program present an increase in peak cardiac output and MHR.
Physical training induces a series of adaptations in skeletal muscle, including increased muscle mass, increased content of mitochondria, increased activity of oxidative enzymes, greater oxygen extraction from the blood, and change in fiber type distribution.
Inflammatory and immune responses play a central role in the development and progression of heart failure. Increased circulating levels of specific cytokines have been detected in these patients. Exercise positively affects such inflammatory markers by improving tolerance to physical activity and attenuating the inflammatory process. Thus, it produces a release of endothelium-derived relaxing factors, whose main representative is nitric oxide, which allows greater vasodilation 103 .
Patients with heart failure also present multiple changes in respiratory function, which may occur as a result of decreased muscle strength secondary to inactivity, causing an increase in respiratory work, both at rest and during exercise. Hence the need for training the respiratory muscles and improve their strength and endurance, which in turn increases exercise tolerance 104 . 
Challenges and goals
Despite the known benefits derived from physical exercise, few patients with heart failure enter CVDPR programs. These patients have poor adherence to these programs, given the physical limitations they present. Therefore, it is important to increase participation and permanence in the program. Moreover, for a more accurate prognostic assessment, as well as for optimal exercise prescription, it is important to perform a cardiopulmonary test. In the absence of this option, the exercise test can provide useful information, although less robust than the former. The completion of the 6-min walk test with pulse oximetry can also contribute to the evaluation and prescription.
Special recommendations
In this type of patients, predominantly aerobic exercises are recommended; they can be performed either continuously or at intervals, with small and gradual increases in frequency and intensity, returning to the previous level when there is decreased tolerance. Dynamic resistance exercises, with a high number of repetitions and low load, can also be performed 105 .
Rehabilitation in patients with valvular heart disease
Definition and facts
The prevalence of valvular heart disease has been changing in our setting in recent decades. Nevertheless, valvular pathology continues to have a significant importance in any cardiology service. It is the most frequent degenerative or nonrheumatic etiology; congenital valvular heart disease has lower incidence 106 . Although valvular heart disease is very common and, in most cases, physical effort is the triggering and limiting factor for symptoms, there are few studies that assess these patients' response and limitations to exercise.
Challenges and goals
Increasing the participation of patients with valvular heart disease in CVDPR programs is challenging. Therefore, it is important to educate referring physicians about the safety of these programs, because fear is the main cause of low indication of physical activity for these patients.
Specific recommendations
The guidelines or recommendations about exercise in this group of patients are directed primarily to lesions that have a moderate or severe degree, because patients with mild and asymptomatic lesions without hemodynamic repercussion have no restriction to the practice of noncompetitive physical activity (Table 18) 29, 107 . Valvular diseases may be accompanied by some degree of severity of pulmonary hypertension; although patients benefit from CVDPR programs, there is not enough scientific evidence to recommend their use.
Rehabilitation in patients with peripheral arterial disease
Definition and facts
Atherosclerosis of the lower limbs, also known as peripheral vascular (or arterial) disease, has an annual incidence estimated at 20 per 1,000 individuals aged > 65 years. This pathology generates ischemic pain (intermittent claudication) that may cause physical limitations in affected individuals, with risk of loss of the extremity. 94 
Objectives
• One of the key recommendations for patients with type 1 or type 2 diabetes is the optimal control of blood glucose, which has been shown to decrease the incidence of diabetes-related microvascular complications 97 
Cardiovascular rehabilitation
• Regular exercise helps to maintain appropriate levels of blood glucose and is a class I indication in the management of patients with diabetes mellitus
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• The environment of cardiovascular rehabilitation is an excellent opportunity for the medical staff to monitor and manage diabetes mellitus, because of the frequent and close contact developed between the medical personnel and the patient • Aerobic and strength exercises may cause hypoglycemia in patients with diabetes, particularly in those individuals with strict blood glucose control. This provides a positive feedback regarding the effects of exercise on blood glucose control 98 • Education and guidance are given to patients identified at risk of hypoglycemia and hyperglycemia; hypoglycemia should be properly treated to avoid unnecessary consumption of calories and weight gain
Complications
• Diabetes is a major risk factor for cardiovascular disease (CVD). Individuals with diabetes are 2-4 times more likely to have a CVD than those without. In addition, CVD occurs at a younger age in individuals with diabetes, who tend to develop more diffuse lesions. Individuals with diabetes have a high prevalence of hypertension (approximately 50%) and dyslipidemia, which contributes to the increase in their CVD risk • Individuals with diabetes, particularly those with long-standing disease, are susceptible to autonomic neuropathies and are less likely to have symptoms, such as angina, while developing myocardial infarction. Therefore, tailoring training exercises that allow the recognition of symptoms of myocardial infarction in this type of patients is not easy. Some patients may have extensive areas of myocardial ischemia before developing any chest pain or the equivalent of angina • Some individuals with diabetes can develop long-term complications, which make cardiovascular rehabilitation even more challenging. Some examples comprise blindness, kidney disease, peripheral neuropathy with decreased sensitivity, peripheral vascular disease with significant claudication or amputation of finger(s)/limb(s), inability to decrease the heart rate response to exercise, and orthostatic hypotension 100-102 Intermittent claudication of the lower limbs is defined as a pain of sufficient intensity that requires the patient to stop walking. It is caused by exercise; it is relieved by rest, and is originated by occlusive arterial disease 108 .
The incidence of symptoms in the general population ranges between 0.9% and 6.9% in men and 1% in women 109 . The finding of intermittent claudication in a patient should not be considered as an isolated symptom, but rather as a systemic disease that manifests in the lower limbs and has impacted the musculoskeletal system, and that such patients probably have other CVD risks, not necessarily related to this symptom. In fact, 5%-10% patients will have a nonfatal cardiovascular event within 5 years.
Challenges and goals
CVDPR programs are part of the clinical treatment.
At the time of admission, the members of the CVDPR service must:
• Assess the patient to know his/her medical history: the presence of CVD risk factors, coexistence of coronary artery disease, habitual medication, etc.;
• Conduct and/or request a stress test on the treadmill aiming to identify:
a) The threshold for onset of ischemic pain in the extremities;
b) The peripheral hemodynamic response to exercise;
c) The coexistence of coronary artery disease.
It is important to repeat this test to evaluate the patient's improvement. At the same time, questionnaires to assess quality of life and perception of pain can be applied at the time of rehabilitation admission and after its completion.
In general, 75% of individuals present an improvement in intermittent claudication with exercise combined with peripheral vasodilators and antiplatelet drugs, whereas the remaining 25% exhibit worsening of their condition. Of these, 5% require vascular intervention and 2% undergo amputation 110 .
Specific recommendations
One of the most frequent mistakes in this group of patients is pushing them to walk at a pace close to the maximum pain of claudication. This causes distress to the patients and the discomfort does not disappear after rest, which discourages them to adhere to the program. The correct recommendations regarding scheduled walks for patients with claudication are as follows 111 :
• Intensity: moderate and gradual. Rest for brief periods until the pain disappears, restart the walk immediately after;
• Duration: start with 5 min of intermittent walk, then progress to 50 min;
• Type of exercise: treadmill and walk without reaching the maximum pain threshold;
• Resistance exercises can be performed in addition to aerobic exercises, but should not replace them;
• Components of each session: warm-up and cool-down periods, lasting 5-10 min each, with a walk in the field or the treadmill;
• Frequency: 3-5 times/week. Ideally, these exercises should be performed daily.
Exercise programs with walks are successful when lasting no less than a few months 22 .
Rehabilitation in post-heart transplantation patients
Definition and facts
Despite receiving a heart with normal systolic function, the transplanted patient experiences exercise intolerance after surgery. This intolerance is caused by the absence of sympathetic innervation of the myocardium, skeletal muscle abnormalities (that develop before transplantation for heart failure), and decreased skeletal muscle strength 112 .
Patients who undergo transplantation are characterized by the following:
• Differences in cardiopulmonary and neuroendocrine responses;
• High RHR (above 90 beats/min);
• Elevated systemic BP and systemic BP at rest, because of the increased plasma norepinephrine and immunosuppressive drugs, such as cyclosporine, a medication that causes an increase in BP at rest and during submaximal exercise.
Challenges and goals
• Decrease basal HR with training;
• Increase HR during submaximal work;
• Avoid overweight or lose weight, thus balancing the side effects of immunosuppressive therapy;
• Maintain BP < 130/80 mmHg;
• Offer the patient a support for his/her psychosocial management.
Specific recommendations
An echocardiogram can be used by a physician to discard pericardial effusion and evaluate ventricular function, as well as to provide information to the patient and family about changes in vital functions derived because of transplantation.
Regarding physical activity, the ideal is to start with slow walks, between 1.5 and 2 km, slowly increasing the distance, keeping the perception of effort according to the Borg scale between 12 and 14. Aerobic exercise should be performed with an intensity of < 50% of peak VO 2 or 10% below the anaerobic threshold (guided by HR). Training should start immediately after hospital discharge, progressing to phase II between the 2 nd and 3 rd week after transplantation.
Exercise should be stopped during steroid pulse therapy 112 .
Resistance exercises are added at the 6 th and 8 th week. At first, they should be performed with an elastic band (2-3 sets with 10-12 repetitions, with a recovery period of > 1 min between each set and with intensity between 40% and 70% of maximum voluntary contraction 113 ). The goal is to perform 5 sets of 10 repetitions with 70% of maximum voluntary contraction and a full recovery.
The total duration of the exercise should be from 30-40 min/day, combining aerobic and resistance exercises, progressing slowly from warm-up to resistance activities.
It is also important to establish a diet to maintain the ideal weight, as well as to control cholesterol levels, DM, and BP, because these patients are very sensitive to excessive salt intake. It is also necessary to inform the patient regarding the adoption of measures to decrease the risk of infection after the transplantation. Adequate psychosocial support is very helpful to manage depression, which is increased by the use of steroids and the high level of anxiety generated by the transplantation itself 112 .
Rehabilitation in patients with pacemakers and cardiac defibrillators
Definitions and facts
The benefit of these devices in decreasing episodes of sudden death and improving quality of life has already been demonstrated; however, a significant incidence of depression, anxiety, and phobias has been described. For this reason, most of the research is in agreement regarding the recommendation of appropriate and ongoing support, as well as psychological and educational counseling 114, 115 .
Challenges and goals
Because physiological changes of exercise can increase the likelihood of the defibrillator (implantable cardioverter-defibrillator [ICD]) being triggered, both the medical team and the patient fear the practice of physical activities. Thus, overcoming this fear and increasing the number of patients referred to a CVDPR program is challenging 12 
.
The following must be known prior to physical activity initiation:
• Patient's pathology;
• Basic information of the pacemaker, such as type of sensor that adjusts HR, as this will determine, in some patients, the HR response to exercise, especially in those without adequate chronotropic response. This factor should be taken into account when prescribing physical activity.
• The device's programming, such as MHR at which it is programmed to send a shock.
It is important to determine the limits of exercise (10-20 bpm below HR at which ICD is programmed to send a shock). A stress test will determine THR; the goal should be to exercise at 75% THR in the first month and at 85% in the second month.
Group work results in great psychological benefits, facilitating the exchange of experiences and feelings, helping patients to lose their fear. Groups are formed in a gradual manner by bringing together old and new patients. The former serve as guides for the latter, demonstrating that it is possible to make major efforts to improve physical capacity without the risk of complications 115 .
Special recommendations
They will depend on the type of pacemakers implanted:
• Unicameral (VVI) without adaptive response, but with good chronotropic response: the physician should treat the patient in a similar way to individuals without CVD. An improvement in the maximum O 2 consumption and anaerobic threshold can be anticipated, with an increase in functional capacity.
• Unicameral VVI without adaptive response and without chronotropic response: it is indicated for physical training without restrictions. However, in these patients, although it improves functional capacity, there is a smaller increase in the consumption of peak O 2 and cardiac output.
• Unicameral VVIR (with adaptive response) will adjust to the exercise HR. However, if the pacemaker sensor is based on an accelerometer that detects axial movement, the adaptation of HR may not be adequate during activities of moderate or high intensity that do not induce axial movement, such as stationary bike.
It is recommended not to perform exercises with weights or to raise the arms excessively until at least 6 weeks after implantation. The patient should always maintain a direct relationship with the arrhythmologist in charge, to define adjustments in the program. In most cases, and especially in patients who survived sudden death, the psychological effects are very important. A specific and individualized treatment by psychologists and psychiatrists is necessary to improve the quality of life and prognosis, as there is evidence of the relationship between psychological impact, ventricular arrhythmias, and ICD shocks 116 .
A test run of the pacemaker should be performed on each patient prior to their entry in the CVDPR program, to monitor vital signs, symptoms in response to exercise, and change of pace. In addition to pacemaker programming, age, and level of physical activity of the patient should be taken into account 116 .
The percentage of HR achieved, METS, and perceived exertion calculated using the Borg scale, will determine the calculation of exercise intensity. Adequate planning of the training will result in an improvement in functional capacity and morbidity, directly related to the etiology and severity of the underlying CVD. One of the main goals is to give patients in CVDPR programs confidence and security in face of possible shocks or arrhythmias during exercise or during their daily lives, and to help them overcome their fears and anxieties regarding the change in their quality of life 115 .
Rehabilitation in patients with chronic obstructive pulmonary disease
Definition and facts
Patients with pulmonary disease associated with stable cardiac disease should not be excluded from a CVDPR program; it is only required that they are stable and properly medicated. These patients develop progressive limitations, often without cardiac involvement. Chronic obstructive pulmonary disease progressively damages the lung tissue and airways, finally resulting in slow deterioration of the respiratory reserve. This picture is complicated with hypoxemia and elevated pulmonary vascular pressures, leading to right ventricular dysfunction.
All these factors contribute to the sensation of dyspnea and worsening of exercise capacity, which lead to a reduction in daily physical activity. The lack of exercise leads to a loss of peripheral physical condition, and ultimately decreases resistance and increases muscle weakness and atrophy, resulting in a greater functional impairment. However, patients with severe respiratory deterioration and respiratory muscle weakness significantly benefit from intensive pulmonary rehabilitation. Similarly, hypoxemia due to physical activity has been considered by some to be a contraindication to an exercise program; this can be a particular case for a patient with aggregated coronary artery disease, but can be performed in a properly monitored and decompensated patient. It is desirable to have a pulse oximeter to measure O 2 saturation during exercise. A decrease in saturation <88% is an indication for a transient break 117 or of the need for supplemental oxygen during physical training, using a nasal catheter or even a Venturi mask.
Challenges and goals
• Get the patient to tolerate the prescribed exercise program;
• Conduct a joint assessment with the pulmonologist to establish an adequate medication regime to allow for the performance of an exercise program; Adequately quantify the level of inability to prescribe the appropriate exercise load;
• Control the CVD risk factors;
• Control the depression and anxiety produced by the sensation of dyspnea;
• Improve muscle strength and decrease muscle atrophy;
• Improve the quality of life of patients by improving their functional capacity with exercise;
• Decrease the rest period between each exercise period.
Specific recommendations
• It is important to evaluate the respiratory and cardiovascular parameters before starting the program. It is advisable to perform a standard chest radiography, spirometry, and echocardiography, in addition to a cardiopulmonary stress test or the 6-min walk test. Conducting a standard stress test with oxygen supplementation may be useful in patients with significant hypoxemia at rest or induced by effort.
• The exercise must be divided into 3 types: flexibility, strength, and aerobic exercises. Stretching is part of a routine of exercises that develop flexibility, improve the range of motion, and help the general warm-up session. Exercises with free weights, at low intensity and high frequency, may be included, as well as walking, rowing, swimming, water aerobics, cycling, climbing stairs, and others, which are capable of producing a significant level of cardiopulmonary stress 118, 119 .
• The intensity of the prescribed initial load, from the pulmonary standpoint, must be sufficiently low so that the patient does not feel discomfort.
• The proper intensity for these patients should be determined with training, i.e., 70%-80% of MHR, if possible 118 .
• In the first weeks, the sessions must not extend beyond 20 min. Therefore, strategies to achieve the highest level of the initial stress test should be the ultimate goal 119, 120 .
• Patients with obvious obstruction should be advised to use a fast-acting bronchodilator 15 min before starting physical activity.
• When the patient tolerates exercise loads, these can be increased by approximately 12.5 watts for stationary bicycles and by 9 watts for the hand ergometer, increasing every 6 sessions.
• Psychosocial management: because the psychological changes are common in these patients, it is important to have a psychological evaluation prior to entering the CVDPR program.
Rehabilitation in coronary artery disease patients (after MI, percutaneous coronary revascularization, or after CABG)
Definition and facts
After an acute coronary event, patients should start a physical activity that is compatible with their tolerance (walking, cycle ergometer, etc.) and clinical picture severity. Generally, after 1 week, all patients should be developing an activity that is, at first, of light intensity and prescribed by the professional in charge of their program 121 .
Challenges and goals
CVDPR-based exercise decreases fatal events 25%-40% in the long term. Despite the indisputable benefit of CVDPR, only 15%-30% patients who have suffered a cardiovascular event participate in this type of programs, in addition to the decreasing adherence observed in patients who choose to participate. Thus, it is important to foster constancy and adherence of such patients to the CVDPR program 12, 122 .
Special recommendations
• A stress test and a neuromusculoskeletal assessment should be performed when patients start the CVDPR program. If the patient starts the program before the stress test, the test should be conducted within the first 4-7 weeks; the results will be used to adjust the exercise prescription.
All post-ACS or CABG patients should undergo a stress test with ECG analysis (when technically feasible) or an equivalent noninvasive test to assess ischemia in the first 4-7 weeks after hospital discharge (level of evidence IIa-C) 29 .
• As a general rule, physical activity (leisure, professional, and sexual activity) should restart at 50% of maximal exercise capacity, expressed in METS, and should be increased gradually.
• Patients who have a preserved left ventricular systolic function and present no inducible ischemia or arrhythmias in a stress test can return to their jobs. If they have an office job, an 8-h daily activity can be restarted. If the work is manual and involves physical activity with moderate or intensive exertion, the workload should not exceed 50% of maximal exercise capacity assessed in the stress test. The workday should not exceed 4 h in the first month, with progressive 2-h increases monthly 29 .
• Patients with moderate left ventricular systolic dysfunction or mild ischemia on a stress test can resume office work, but their activity should be limited to stationary desk work.
• A patient with severe left ventricular systolic dysfunction or significant ischemia on a stress test can engage in office work whenever the exercise capacity is > 5 METS without symptoms. If not, the patient should abstain from work 29 .
Rehabilitation in patients with vasovagal syndrome
The vagal or vasovagal syncope is a common entity with an estimated prevalence of approximately 35% [123] [124] [125] [126] .
The use of fluids and salt has been widely recommended for the treatment of this pathology 127, 128 . Certain isometric exercises (counter-pressure) have been used as abortive for episodes that are preceded by a prodrome. These exercises are designed to quickly increase peripheral arterial resistance and, therefore, prevent syncope due to a decrease in BP. The main counter-pressure exercises are handgrip, flexing the upper extremities, clasping both hands and trying to separate them, and flexing the lower extremities [129] [130] [131] . Another effective method for preventing new episodes is the practice of supervised exercises, in which the patient remains in the standing position, leaning against the wall, with increasing duration, reaching up to 30 min 132 . Regular aerobic exercise should be recommended, because they are almost always effective in decreasing the symptoms by increasing the volume of blood and muscle mass in the lower limbs, as well as enhancing venous return 130 . Evidence has shown that a regular exercise program, comprising aerobic activities and resistance exercises, increases the sensitivity of arterial baroreceptors, when compared with pharmacological treatment 133 .
Cost effectiveness of a cardiovascular rehabilitation program
Cost effectiveness measures the years and quality of life gained; it is usually expressed in monetary terms over the years gained. When discussing the cost/benefit ratio or cost effectiveness, the costs of an intervention are also measured, combined with the disease-related costs, including complications or long-term events. The results are expressed in terms of clinical benefit (years of life gained) divided by the monetary value (cost), resulting in cost of every extra year of life in comparison with alternative treatment or no treatment.
Several studies have shown that CVDPR is cost effective and that it can even be cost saving, because it not only increases survival but also decreases costs. Ades et al. 134 analyzed the cost/benefit ratio of 21 months of CVDPR, and found savings of USD 739 compared with the control group; Oldrige et al. 135 evidenced savings of USD 9,200 in comparison with the control group, over a period of 12 months. To compare the cost effectiveness of CVDPR with that of other interventions we can cite the typical treatment of hypertension, which has a cost effectiveness of USD 9,000. This proves that CVDPR is useful in terms of survival, incidence of cardiovascular events, quality of life, and also from an economic standpoint.
V. CONCLUSIONS
Presently, CVDPR is regarded as safe and effective, decreasing the overall CVD-related mortality and the number of cardiovascular events; it also decreases hospitalizations, improves symptoms and quality of life, and is cost effective. Although it is recommended in all guidelines for clinical practice, its implementation in our environment is suboptimal and frustrating.
Human and material resources to develop these programs in a standardized, accessible, and universal manner should be provided. The attitude and collaboration of physicians in the hospitalization phase is important for the referral of patient to CVDPR programs and the success of such programs. A favorable attitude toward rehabilitation will facilitate modification of the daily routines of a larger number of patients.
Program design and the attitude of the professionals can lead to poor adhesion to the guidelines, if they are not adjusted to the patients' circumstances. Less-intensive and/or semi-supervised home programs should be considered in specific cases. Fewer women enroll in CVDPR programs than men; they also tend to abandon the program earlier. This is attributed to their higher age, increased prevalence of pathologies associated with depression, decreased social support, and increased family obligations. A similar effect occurs in depressed patients and those of low socioeconomic background. Lack of exercise and poor feeding habits are creating a shift in the cardiovascular profile of the population, which implies an earlier appearance of clinical manifestations of CVD and increased prevalence of risk factors, such as physical inactivity and overweight. These circumstances cause serious public health problems, which must be corrected with educational measures aimed at the entire population, fostering mainly primary prevention programs. Therefore, we believe that governments, through their health policies, should become more involved in promoting and performing actions that have a real impact on society.
In a 1993 statement, WHO proposed that CVDPR should not be considered as an isolated therapy, but rather as a treatment integrated in the overall management of CVD and as an active component of secondary prevention.
